The US Food and Drug Administration (USFDA) granted the miltefosine orphan drug designation in 2016 for treating Acanthamoeba keratitis. This study evaluates miltefosine’s in vitro effic
SUMMARY This study aimed to evaluate the effectiveness of the active ingredient oxfendazole and the association of this with levamisol, reduction of eggs per gram of feces (EPG) and larvae of helmint
Toxoplasma gondii is an important pathogenic protozoon that infects up to one-third of the world's population. In immunocompetent individuals, the infection generally is asymptomatic. However, in immu
